€655.50
Your prediction
Regeneron Pharmaceuticals Inc. Stock
Regeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Pros and Cons of Regeneron Pharmaceuticals Inc. in the next few years
Pros
Cons
Performance of Regeneron Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 2.270% | -0.141% | 0.615% | 24.347% | -3.815% | -12.437% | 56.406% |
| IQVIA Holdings Inc. | -9.420% | -0.828% | 4.212% | 19.046% | -22.475% | -17.384% | -20.436% |
| Incyte Corp. | -0.480% | 0.413% | 5.168% | 64.451% | -1.900% | 21.715% | 17.894% |
| Vertex Pharmaceuticals Inc. | -0.010% | -0.120% | -4.860% | -12.915% | -4.544% | 24.116% | 108.023% |
Comments
News
Regeneron Pharmaceuticals: A Strong Contender in the Biotech Arena
Explore the exciting world of Regeneron Pharmaceuticals (NASDAQ: REGN) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable
Is Regeneron a Multimillionaire-Maker Stock?
Regeneron (NASDAQ: REGN) has encountered several headwinds over the past two years, including the loss of patent exclusivity for one of its growth drivers, Eylea, a medicine for wet age-related
Is Eli Lilly's Weight Loss Empire in Trouble?
Over the past two years, Eli Lilly (NYSE: LLY) has established itself as the leader in the weight loss market. That's thanks to the company's tirzepatide, a compound sold under the brand name